New WHO global guidance puts forward recommendations for more effective and equitable clinical trials
what
The World Health Organization (WHO) last month released guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels. This guidance aims to support stronger country-led research and development (R&D) ecosystems to advance health science so that new, safe and effective health interventions can be made more accessible and affordable globally for people everywhere, faster.
On 13 December 2024, at 14:00 CET, the WHO, together with The Global Health Network are presenting the key aspects of the recent groundbreaking publication. Do not miss this opportunity to hear directly from WHO and learn how this guidance can help support and strengthen your research. Link to registration for the webinar below.
Who
Researchers, SMEs and all stakeholders from public and private research institutions in Health
When
December 13, 2024 - 14:00
Further information
The guidance which was developed was developed in an extensive and inclusive process, involving nearly 3000 stakeholders from various sectors across 48 countries, includes practical considerations for setting up trials to include pregnant and lactating women, given they have unique healthcare needs. In general, at-risk populations should be involved from the earliest stages. To facilitate this, safety should be assessed as an initial priority, for instance, by reviewing comparable interventions or expediting pre-clinical studies for these groups. Appropriate procedures for consent and assent are key, particularly for children.
The guidance recommends putting patient, participant and community engagement at the heart of organizing clinical trials, to ensure that research planning, delivery and dissemination meets public needs and maintains trust.
The new guidance also seeks to strengthen national R&D ecosystems through sustainable financing, to support better decision-making, accelerate access to health innovation and build more robust and effective national and global health research environments. For more information, please se the link below.